Clinical Trials Browser

Neoplasms

NCT07525141 2026-04-13

A Study of JNJ-1761981 in Participants With Solid Tumors

Phase 1 Not yet recruiting

66 enrolled

Tumor-Agnostic

Neoplasms

NCT07519564 2026-04-09

A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia

Phase 1 Not yet recruiting

18 enrolled

Cachexia, Neoplasms

NCT07476326 2026-04-03

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

Phase 1 Not yet recruiting

120 enrolled

Dermatologic

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms

NCT07496073 2026-03-27

A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion in Adult Subjects With Recurrent or Progressive Malignant Primary Brain Tumors（CROWN）

Phase 1 Not yet recruiting

30 enrolled

CNS

Brain Neoplasms, Neoplasms, Neurologic Manifestations

NCT07454031 2026-03-13

Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

Phase 1 Not yet recruiting

22 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT07462468 2026-03-13

A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.

Phase 1 Not yet recruiting

36 enrolled

Gynecologic

Neoplasms, Ovarian Neoplasms

NCT07454668 2026-03-06

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

Phase 1 Not yet recruiting

20 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT07217028 2026-02-27

Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma

Phase 1 Not yet recruiting

60 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Neoplasms

NCT07224776 2026-02-27

Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria

Phase 1 Not yet recruiting

20 enrolled

Neoplasms, Proteinuria

NCT07368127 2026-01-26

A Study of TPD3310 in Patients With Advanced Malignant Tumors

Phase 1 Not yet recruiting

112 enrolled

Tumor-Agnostic

Neoplasms

NCT07054944 2025-12-15

T-LyM

Phase 1 Not yet recruiting

10 enrolled

Sarcoma

Neoplasms, Neoplasms, Germ Cell and Embryonal, Rhabdomyosarcoma, Sarcoma

NCT07192471 2025-09-25

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Phase 1 Not yet recruiting

72 enrolled

DermatologicLymphoid

Immune System Diseases, Lymphoma, Mycosis Fungoides, Neoplasms, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT07119996 2025-08-13

Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

Phase 1 Not yet recruiting

12 enrolled

Genitourinary

Urinary Bladder Neoplasms, Neoplasms

NCT07072325 2025-08-03

Safety, Tolerability, PK, and Efficacy of CD-001 in Advanced Head & Neck Cancers

Phase 1 Not yet recruiting

9 enrolled

Head & Neck

Head and Neck Neoplasms, Neoplasms

NCT07057349 2025-07-09

CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer

Phase 1 Not yet recruiting

40 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT07053735 2025-07-08

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

Phase 1 Not yet recruiting

30 enrolled

Genitourinary

Urinary Bladder Neoplasms, Neoplasms

NCT06956261 2025-05-04

NW-301 TCR-T in Patients With Advanced Solid Tumor

Phase 1 Not yet recruiting

44 enrolled

Tumor-Agnostic

Neoplasms

NCT06754761 2025-01-01

Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib

Phase 1 Not yet recruiting

8 enrolled

GynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06742593 2024-12-19

Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors

Phase 1 Not yet recruiting

12 enrolled

CNS

Brain Neoplasms, Neoplasms, Neurologic Manifestations, Central Nervous System Neoplasms

NCT06389526 2024-09-19

A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors

Phase 1 Not yet recruiting

48 enrolled

Tumor-Agnostic

Neoplasms

NCT06558175 2024-08-16

REPAIR

Phase 1 Not yet recruiting

48 enrolled

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Neoplasms

NCT06528249 2024-07-30

Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies

Phase 1 Not yet recruiting

39 enrolled

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

NCT05361954 2023-04-12

Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors

Phase 1 Not yet recruiting

36 enrolled

GastrointestinalSarcoma

Neoplasms, Pancreatic Neoplasms, Sarcoma

Clinical Trials

Open Label Clinical Trial of Intravenous Crotoxin Part 3

A Study of JNJ-1761981 in Participants With Solid Tumors

A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion in Adult Subjects With Recurrent or Progressive Malignant Primary Brain Tumors（CROWN）

Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma

Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria

A Study of TPD3310 in Patients With Advanced Malignant Tumors

T-LyM

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

Safety, Tolerability, PK, and Efficacy of CD-001 in Advanced Head & Neck Cancers

CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

NW-301 TCR-T in Patients With Advanced Solid Tumor

Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib

Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors

A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors

REPAIR

Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies

Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors